메뉴 바로가기
메인 본문 바로가기
페이지 하단 바로가기
HOME
ABOUT
Overview
Management
Extenal collaboration
OUR SCIENCE
Cancer Metabolism
CID
PIPELINE
Pipeline
Patent
Certificate
Clinical trials
CONTACT
Contact us
Notice
ENG
KOR
SITEMAP
HOME
ABOUT
Overview
Management
Extenal collaboration
OUR SCIENCE
Cancer Metabolism
CID
PIPELINE
Pipeline
Patent
Certificate
Clinical trials
CONTACT
Contact us
Notice
Contact
This is a contact us & notice from Metimedi Pharmaceuticals..
Contact us
Notice
Notice
NO.
Title
Writer
Date
Views
14
Completed submitting the poster to the Korean Cancer Society
Admin
2020.11.16
79
13
[OMT-110 Main Patent] Receiving European patent application certificate
Admin
2020.10.29
175
12
[CID Patent] Receiving US Patent Application Certificate
Admin
2020.10.13
317
11
Receiving U.S. Trademark Registration Certificate
Admin
2020.10.07
440
10
[OMT-110 Main Patent] Approving responses submitted to the Mexico Patent Office
Admin
2020.09.29
509
9
[OMT-110 Main Patent] Obtained Official European Patent Number
Admin
2020.09.29
365
8
[OMT-110 Main Patent] Receiving notice of permission for Ukraine patent application
Admin
2020.09.29
917
7
ASCO (American Society of Clinical Oncology) OMT-110 Clinical Phase 1 Results Announcement
Admin
2020.09.29
930
6
AACR (American Association for Cancer Research) e-poster registration completed
Admin
2020.09.29
244
5
Gachon University Gil Medical Center Newsletter July 2020
Admin
2020.09.28
931
1
2
Title
Content
Search
